Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Biologic Awarded CFDA Approval to Manufacture Plasma Product

publication date: Oct 20, 2014
China Biologic Products, a Beijing-based plasma company, received CFDA approval to begin commercial manufacturing of human prothrombin complex concentrate (PCC) at its Shandong Taibang facility. For China Biologic, PCC represents new revenue from plasma that would otherwise be discarded. China Biologic, which expects to receive a GMP certificate for the facility before year-end, will also produce PCC from its recently completed Guizhou Taibang facility. More details....

Stock Symbol: (NSDQ: CBPO)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital